Sponsor
Vaccitech PLC
Unit 6-10, Zeus Building, Rutherford Avenue, Harwell Oxford, OX11 0DF, United Kingdom
About the sponsor
Prostate cancer is the central therapeutic area, with clinical research focused on men experiencing biochemical recurrence after definitive local treatment.
- Prostate cancer immunotherapy
- Biochemical recurrence
- PSA response
The sponsor’s clinical activity is directed toward immune-based approaches in urologic oncology, with attention to disease control in recurrent prostate malignancy.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.